Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
65 participants
INTERVENTIONAL
2024-05-07
2026-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of an Intimate Partner Violence Screening-Intervention
NCT00257296
Impact of Family-Centered Care for Intimate Partner Violence (IPV)
NCT06071299
Strength for U in Relationship Empowerment
NCT04218864
Forging Hopeful Futures to Reduce Youth Violence
NCT05743478
Feasibility Study of Couple Therapy Treatment for Situational Couple Violence
NCT03498638
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The Pilot Stage will utilize micro-longitudinal methods (i.e., daily self-reports of hope, self-worth, empowerment, and emotional wellbeing for 14 days before and after the intervention) to assess changes in these constructs. Eligible participants will take part in a baseline interview with a member of the research team. Baseline measures will be based on participant self-report and used to characterize the sample and collect data on person-level control variables. Beginning the day after the baseline interview, participants will complete a brief daily survey on their smartphone. On day 15, participants will receive a link to the SSI and be asked to complete it that day; immediately following the SSI, participants will be asked to complete the post-intervention survey/process supplement to aid in the process evaluation. After completion of the SSI, survivors will participate in 14 additional days of daily data collection to establish post-intervention outcome measures.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single-Session Intervention to Promote Hope
A 30-45 minute self-guided intervention delivered in a web browser.
Single-session intervention (SSI)
The SSI focuses on increasing hope among women who experience IPV using facts about the brain and IPV research, stories from survivors, and writing exercises.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Single-session intervention (SSI)
The SSI focuses on increasing hope among women who experience IPV using facts about the brain and IPV research, stories from survivors, and writing exercises.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Self-identify as a woman (cis- or trans-gender woman)
* Currently in a relationship of at least 3 months duration in which they have experienced physical IPV by a male partner
* Have a smartphone that is compatible with the MyCap app to be able to participate in daily surveys.
Exclusion Criteria
* Have experienced significant psychiatric instability based on self-reported inpatient psychiatric hospitalization in the past 3 months
* Reports having a conservator of person
* Not comfortable conversing, reading, or writing in English
* Participated in a Listening Session in the development phase of this study.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Office on Violence Against Women (OVW)
UNKNOWN
Center for Family Justice
UNKNOWN
Connecticut Coalition Against Domestic Violence
UNKNOWN
Yale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tami Sullivan, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Psychiatry, Yale School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Consultation Center at Yale
New Haven, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15JOVW-22-GG-04755-STOP
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
2000034173
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.